Salud financiera de hoja de balance de Spirox

Salud financiera controles de criterios 4/6

Spirox tiene un patrimonio de los accionistas total de NT$2.2B y una deuda total de NT$116.9M, lo que sitúa su ratio deuda-patrimonio en 5.3%. Sus activos y pasivos totales son NT$2.8B y NT$560.9M respectivamente.

Información clave

5.3%

Ratio deuda-patrimonio

NT$116.92m

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	NT$1.40b
Patrimonio	NT$2.21b
Total pasivo	NT$560.88m
Activos totales	NT$2.77b

Actualizaciones recientes sobre salud financiera

Recent updates

Optimistic Investors Push Spirox Corporation (TWSE:3055) Shares Up 26% But Growth Is Lacking

Oct 28

Is Spirox (TWSE:3055) Weighed On By Its Debt Load?

Sep 10

Spirox Corporation's (TWSE:3055) Popularity With Investors Under Threat As Stock Sinks 27%

Aug 10

Is Spirox (TWSE:3055) Using Too Much Debt?

Apr 29

Does Spirox (TPE:3055) Have A Healthy Balance Sheet?

Apr 07

Spirox Corporation (TPE:3055) Investors Should Think About This Before Buying It For Its Dividend

Mar 03

Spirox Corporation's (TPE:3055) Shareholders Might Be Looking For Exit

Feb 05

Here's Why We Don't Think Spirox's (TPE:3055) Statutory Earnings Reflect Its Underlying Earnings Potential

Jan 15

Spirox (TPE:3055) Is Making Moderate Use Of Debt

Dec 23

Introducing Spirox (TPE:3055), A Stock That Climbed 76% In The Last Three Years

Nov 27

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$1.9B) de 3055 superan a sus pasivos a corto plazo (NT$405.3M).

Pasivo a largo plazo: Los activos a corto plazo de 3055 (NT$1.9B) superan a sus pasivos a largo plazo (NT$155.5M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: 3055 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de 3055 ha pasado de 28.5% a 5.3% en los últimos 5 años.

Cobertura de la deuda: El flujo de caja operativo de 3055 es negativo, por lo que la deuda no está bien cubierta.

Cobertura de intereses: Datos insuficientes para determinar si los pagos de intereses de 3055 sobre su deuda están bien cubiertos por el EBIT.

Salud financiera de hoja de balance de Spirox

Salud financiera controles de criterios 4/6

Información clave

Actualizaciones recientes sobre salud financiera

Is Spirox (TWSE:3055) Weighed On By Its Debt Load?

Is Spirox (TWSE:3055) Using Too Much Debt?

Does Spirox (TPE:3055) Have A Healthy Balance Sheet?

Spirox (TPE:3055) Is Making Moderate Use Of Debt

Recent updates

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Spirox Corporation to Report Q3, 2024 Results on Nov 06, 2024

Optimistic Investors Push Spirox Corporation (TWSE:3055) Shares Up 26% But Growth Is Lacking

Is Spirox (TWSE:3055) Weighed On By Its Debt Load?

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Spirox Corporation's (TWSE:3055) Popularity With Investors Under Threat As Stock Sinks 27%

Spirox Corporation to Report Q2, 2024 Results on Aug 07, 2024

Dividend of NT$1.01 announced

First quarter 2024 earnings released: NT$0.90 loss per share (vs NT$0.91 profit in 1Q 2023)

Spirox Corporation announced a financing transaction

Is Spirox (TWSE:3055) Using Too Much Debt?

Full year 2023 earnings released: NT$0.49 loss per share (vs NT$2.20 profit in FY 2022)

Spirox Corporation, Annual General Meeting, Jun 19, 2024

Investor sentiment deteriorates as stock falls 18%

New major risk - Share price stability

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 15%

New minor risk - Shareholder dilution

Spirox Corporation and Southport Corporation Launch Non-Destructive SiC Defect Inspection System

Second quarter 2023 earnings: Revenues in line with analyst expectations

Spirox Corporation Announces Appointments to the Risk Management Committee

Spirox International Limited Announces Resignation of Yang, Yao-Chou, Institutional Director

Investor sentiment improves as stock rises 23%

New major risk - Share price stability

New major risk - Earnings quality

Investor sentiment deteriorates as stock falls 20%

Upcoming dividend of NT$1.00 per share at 2.4% yield

New minor risk - Share price stability

Investor sentiment improves as stock rises 20%

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: NT$1.02 (vs NT$1.41 loss in 3Q 2021)

Second quarter 2022 earnings released: NT$0.68 loss per share (vs NT$0.90 loss in 2Q 2021)

Upcoming dividend of NT$0.20 per share

First quarter 2022 earnings released: NT$0.76 loss per share (vs NT$1.02 loss in 1Q 2021)

Less than half of directors are independent

Full year 2021 earnings released: NT$3.70 loss per share (vs NT$0.48 loss in FY 2020)

Third quarter 2021 earnings released: NT$1.41 loss per share (vs NT$0.32 profit in 3Q 2020)

Upcoming dividend of NT$0.20 per share

Second quarter 2021 earnings released: NT$0.90 loss per share (vs NT$0.13 profit in 2Q 2020)

First quarter 2021 earnings released: NT$1.06 loss per share (vs NT$0.42 loss in 1Q 2020)

Does Spirox (TPE:3055) Have A Healthy Balance Sheet?

Full year 2020 earnings released: NT$0.48 loss per share (vs NT$0.11 profit in FY 2019)

New 90-day high: NT$35.20

Spirox Corporation (TPE:3055) Investors Should Think About This Before Buying It For Its Dividend

Spirox Corporation's (TPE:3055) Shareholders Might Be Looking For Exit

New 90-day low: NT$29.15

Here's Why We Don't Think Spirox's (TPE:3055) Statutory Earnings Reflect Its Underlying Earnings Potential

New 90-day low: NT$32.15

Spirox (TPE:3055) Is Making Moderate Use Of Debt

Introducing Spirox (TPE:3055), A Stock That Climbed 76% In The Last Three Years

Third quarter 2020 earnings released: EPS NT$0.32

New 90-day high - NT$34.95

First half earnings released

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera